In the original version of this article (1), The HLA profile in panel B of Fig. 2 was inadvertently mislabeled. The error has been corrected in the online HTML and PDF versions of the article. The authors regret this error.
Reference
1.
Ureshino
H
,
Shindo
T
,
Tanaka
H
,
Saji
H
,
Kimura
S
. HLA polymorphisms are associated with treatment-free remission following discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia
. Mol Cancer Ther
2021
;20
:142
–9
.©2022 American Association for Cancer Research
2022
American Association for Cancer Research
